The mechanisms for regulating absorption of Fe bis-glycine chelate and Fe-ascorbate in caco-2 cells are similar.
Inorganic iron (Fe) absorption from the diet is controlled mainly in the intestinal tract where apical Fe uptake is inversely related to the Fe content in the enterocyte. Iron bis-glycine chelate is an iron compound that may be absorbed by a mechanism different from the regulated nonheme Fe pathway. Because Fe bis-glycine chelate is used increasingly as an Fe fortificant in foods, the critical question is whether this compound is a safe Fe supplement. We compared apical Fe uptake and transepithelial transport offered either as (59)Fe bis-glycine chelate or a (59)Fe-ascorbate (Fe-AA) complex in Caco-2 cells, as a model of human intestinal epithelia, grown in different Fe concentrations in the media (0.5, 5 and 20 micro mol/L Fe). Apical Fe uptake from (59)Fe-AA and (59)Fe bis-glycine chelate did not differ nor did transepithelial transport rates. The rate of (59)Fe uptake decreased with increasing intracellular Fe concentration (P < 0.001), an indication of a common absorption regulatory mechanism. We also evaluated the effect of an excess of Fe (100 micro mol/L) provided as Fe bis-glycine chelate or Fe-AA on the incorporation of 1 micro mol/L (55)Fe-AA into Fe-replete Caco-2 cells. The inhibition of Fe bis-glycine chelate on the absorption of the extrinsic tag of (55)Fe-AA (87.5%) did not differ from that of Fe added as Fe-AA (86.8%). These results suggest that Fe derived from Fe bis-glycine chelate and Fe-AA have similar regulatory absorption mechanisms.
Mazariegos
Dora Inés
DI
Micronutrients Laboratory, Institute of Nutrition and Food Technology (INTA), Santiago, Chile.
Pizarro
Fernando
F
Olivares
Manuel
M
Nuñez
Marco T
MT
Arredondo
Miguel
M
D000042:Absorption; D000704:Analysis of Variance; D001205:Ascorbic Acid / Q000493:pharmacokinetics; D001682:Biological Availability; D018938:Caco-2 Cells; D002478:Cells, Cultured; D005296:Ferrous Compounds / Q000493:pharmacokinetics; D005998:Glycine / Q000031:analogs & derivatives* / Q000493:pharmacokinetics; D006801:Humans; D007501:Iron / Q000493:pharmacokinetics*; D008954:Models, Biological
D005296:Ferrous Compounds; C073588:bis-glycino iron II; D007501:Iron; D001205:Ascorbic Acid; D005998:Glycine